SCHEMBL209316

SCHEMBL209316

C[C]C1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3362171 0.96
SCHEMBL7493018 0.89
SCHEMBL1995513 0.73
Acetonitrile SCHEMBL21273814 0.71
SCHEMBL209150 0.69 EPHX1 (0.35)
SCHEMBL2106124 0.69 KCNH2 (0.39)
SCHEMBL1987796 0.69
Ethane SCHEMBL27895280 0.67 KCNH2 (0.30)
Ethane SCHEMBL2154402 0.67 KCNH2 (0.30)
SCHEMBL28360375 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086454-A1 PROCESS FOR PRODUCING SUBSTITUTED LACTONES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2021-05-06 WO claimed
US-20150284615-A1 LOW-VOC DIALKYL-FUNCTIONAL ALKOXYSILOXANES, PROCESSES AND USE THEREOF AS HYDROPHOBIZING IMPREGNATING AGENTS FOR MINERAL BUILDING MATERIALS EVONIK INDUSTRIES AG (DE) 2015-10-08 US claimed
EP-2927291-A1 Low VOC dialkyl-functional alkoxysiloxanes, method and their use as hydrophobizing impregnating agent for mineral building materials Evonik Degussa GmbH (DE) 2015-10-07 EP claimed
US-20140294763-A1 PEPTIDOMIMETIC PROTEASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED 2014-10-02 US claimed
EP-2368877-B1 Peptidomimetic protease inhibitors and intermediates for their preparation As treatment for HCV infection VERTEX PHARMA (US) 2014-05-07 EP claimed
EP-1958956-B1 Peptidomimetic protease inhibitors VERTEX PHARMA (US) 2013-12-11 EP claimed
US-20120282219-A1 PEPTIDOMIMETIC PROTEASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-11-08 US claimed
CN-102504014-A Peptidomimetic protease inhibitors LILLY CO ELI 2012-06-20 CN claimed
US-20120064034-A1 Peptidomimetic protease inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-03-15 US claimed
EP-2368901-A1 Peptidomimetic protease inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-28 EP claimed
JP-2004517047-A 2004-06-10 JP claimed
US-6660858-B2 Made by reacting a benzoxazole with a leaving group at the 2 position and a diamine of given formula LION BIOSCIENCE AG (DE) 2003-12-09 US claimed
CN-1451014-A Peptidomimetic protease inhibitors LILLY CO ELI (US) 2003-10-22 CN claimed
EP-1320540-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-06-25 EP claimed
US-6534503-B1 Treating sexual dysfunction, such as erectile dysfunction or sexual arousal disorder, with a compound having the generic formula X1-X2-(D)Phe-Arg-(D)Trp-X3. A particularly useful compound is HP-228, which has the formula LION BIOSCIENCE AG (DE) 2003-03-18 US claimed
US-20020161028-A1 2-aminobenzoxazole derivatives and combinatorial libraries thereof LION BIOSCIENCE, AG (DE) 2002-10-31 US claimed
WO-2002079753-A2 2-AMINOBENZOXAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2002-10-10 WO claimed
EP-1214330-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-06-19 EP claimed
WO-2002018369-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2002-03-07 WO claimed
WO-2001021634-A1 BENZIMIDAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-03-29 WO claimed